| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.56 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |